Background and aims Fentanyl is primarily responsible for the current phase of the overdose
epidemic in North America. Despite the benefits of treatment with medications for opioid use …

Background Medications for opioid use disorder (MOUD; methadone, buprenorphine,
naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal …

Introduction: In recent years, opioid-related mortality has increased steadily in the United
States. Fentanyl, a synthetic opioid, has been a primary driver of the current wave of …

Background Fentanyl has become widespread in the illicit opioid supply, and is a major
driver of overdose mortality. Methods This study used a medical records review at a …

To the Editor: The letter by Hartley et al. 1 describes a novel approach for buprenorphine
initiation in an inpatient withdrawal management setting for persons who use fentanyl and …

Background and Objectives Opioid‐related overdose deaths in North America have
increased drastically, partially due to the increased prevalence of illicitly manufactured …

Background and Aims: Little is known about how the expansion of opioid agonist therapy
(OAT) and emergence of fentanyl in the illicit drug supply in North America has influenced …

Importance Fentanyl has exacerbated the opioid use disorder (OUD) and opioid overdose
epidemic. Data on the effectiveness of medications for OUD among patients using fentanyl …

Objectives: Despite their efficacy, medications for opioid use disorder (MOUD) are
underutilized in the United States. Nonetheless, few studies have explored reasons why …

Background US opioid overdose deaths continue to climb, with a 12.0% increase from 2016
to 2017. Fentanyl, a synthetic opioid, has been a major contributor to opioid-related …